patients almost invariably have pulmonary hypertension, with thickening of the wal1s of pulmonary arterial capillaries and hypertrophy of right ventricular muscle.
Experimentally in rats the changes are reversed fol1owing correction of the hypoxia (Hunter et al. 1974) . Similarly in man oxygen therapy reduces the pulmonary hypertension (Stark et al. 1973) . So an improvement in mortality and morbidity might also be expected. This has indeed been observed in patients living at an altitude of 5000 feet (1540 m) in Denver, Colorado (Neff & Petty 1970) , but at sea level the changes are less dramatic and dependent on dosage.
In making an assessment of the value of oxygen therapy a number of questions need to be answered. (I) At what level of arterial hypoxaemia should treatment be started? (2) What is the best guide to its effectiveness? (3) Are 12 or 15 hours of therapy per 24-hour day sufficient? (4) What is the optimum dose of oxygen and method of administration? (5) At what level of Pao2 would the symptoms and signs associated with hypoxaemia be relieved? (6) Does therapy influence the steady decline of Pao 2 ?
In the present study 40 disabled patients were randomized between no oxygen therapy and oxygen by nasal catheters for 15 hours per day at a flow rate of 2 I min -I. Mean duration of follow up is so far 18 months.
During this time the treated group have fared rather better than the control group with respect to mortality (4 and 8 deaths out of20) and hospital admissions (13 and 31 respectively). The patients who died had a substantially lower initial Pa0 2 than those still alive (respectively 5.0 and 6.6 kPa), so it may be important to treat early in the natural history of hypoxia than later. The response of the Pa02 to oxygen did not differ between the groups. The initial pulmonary artery pressure was on average 32 mmHg (4.3 kPa) and tended to rise in the control group and this was also the case for the pulmonary vascular resistance (PVR). In the treated group there was a small fall in pressure but no change in PVR. Few of these 'changes reach statistical significance. probably on account of the short period of follow up and wide individual variation. These reservations highlight the twin difficulties of such a study: that the intensive investigation limits the number of patients who can be admitted to the trial, and that a long period of time is required for the therapy to produce an effect. Red cell mass (RCM) shows an initial significant fall in the treated patients, but later there is some escape. Since RCM is possibly one of the most sensitive indicators of the effectiveness of therapy, it may be that present regimes do not give enough oxygen.
Finally, the arterial blood gases measured during breathing air continue to deteriorate in both treated and control groups. There is so far little evidence that oxygen therapy treats the underlying lung disorder.
The value of oxygen therapy depends upon clinical improvement. but in order to regulate therapy it is important to find a physiological variable which parallels the clinical improvement. Red cell mass and pulmonary vascular resistance might perhaps serve for this purpose. The clinical response suggests some value for oxygen therapy, but the trial which is sponsored by the Medical Research Council is not yet complete. In addition the present oxygen regimen may not be optimal.
Dr D C Flenley said that a defect of the trial was that it was not single blind, let alone double blind. Amongst other things this led to difficulty in persuading control subjects to attend for repetition of the physiological tests. Dr Howard had evidence from other studies that the patient's awareness did not influence the response to treatment. One objection to a double blind trial was the cost and this had also been a factor in deciding on an oxygen now rate of 2 I min -I. The trial would provide evidence on the effectiveness of different methods of providing oxygen.
In reply to Dr B M Wright, Dr Howard said that 3 out of20 patients receiving treatment had returned to work. In answer to Dr D C S Hutchison, he said that he had no score of the quality oflife but some patients were able to think better, could write more clearly and spent less time watching television. He had no answer to Dr A E Tattcrsfield's query on what improvement in life expectation would offset the cost and inconvenience of the treatment.
In reply to Dr J E Cotes, who asked if the trial had begun at the right time, Dr Howard said one had to get one's feet wet. The present study was probably only a beginning and would be folIowed by others designed to answer some of the questions posed by the present investigation.
